| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |